Renal Denervation Lowered Resistant Hypertension

Selective renal denervation for the treatment of resistant hypertension continues to rack up impressively large and durable blood pressure reductions and a solid safety profile 3 years post-procedure, according to the latest update from the Symplicity HTN-1 study, an open-label, uncontrolled investigation. Dr. Paul A. Sobotka discusses the results. See the related story at http://tinyurl.com/6sfkpp3